We are live on ! Find out more
BC

Birchview Capital Portfolio holdings

AUM $176M
1-Year Est. Return 95.04%
This Fund
S&P 500
This Quarter Est. Return
+36.73%
1 Year Est. Return
+95.04%
3 Year Est. Return
+233.14%
5 Year Est. Return
+280.2%
10 Year Est. Return
+1,023.63%
AUM
$171M
AUM Growth
+$33.6M
Cap. Flow
-$1.93M
Cap. Flow %
-1.13%
Top 10 Hldgs %
91.64%
Holding
48
New
3
Increased
6
Reduced
2
Closed
5

Top Buys

Rank Stock Value
1
CFRX
ContraFect Corporation
CFRX
+$613K
2
SITO
SITO MOBILE, LTD
SITO
+$534K
3
ALDR
Alder Biopharmaceuticals
ALDR
+$305K
4
OPK icon
Opko Health
OPK
+$201K
5
VCYT icon
Veracyte
VCYT
+$195K

Top Sells

Rank Stock Value
1
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$2.1M
2
MDVN
MEDIVATION, INC.
MDVN
+$1.13M
3
RLYP
RELYPSA INC COM
RLYP
+$333K
4
CELG
Celgene Corp
CELG
+$216K
5
RPTP
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
+$215K

Sector Composition

Rank Sector Weight
1 Healthcare 95.47%
2 Energy 3.24%
3 Consumer Staples 0.54%
4 Industrials 0.36%
5 Consumer Discretionary 0.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ADXS
26
DELISTED
Advaxis Inc
ADXS
$381K 0.22%
2,373
– –
KURA icon
27
Kura Oncology
KURA
$956M
$369K 0.22%
59,114
– –
BIIB icon
28
Biogen
BIIB
$29.8B
$313K 0.18%
1,000
– –
XNCR icon
29
Xencor
XNCR
$1.41B
$301K 0.18%
12,300
– –
MACK
30
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
$279K 0.16%
5,592
– –
VCYT icon
31
Veracyte
VCYT
$4.62B
$263K 0.15%
+34,567
New +$195K
CELGZ
32
DELISTED
Celgene Corporation Contingent Value Rights
CELGZ
$248K 0.14%
238,214
– –
PACB icon
33
Pacific Biosciences
PACB
$422M
$242K 0.14%
27,000
– –
WKHS icon
34
Workhorse Group
WKHS
$30.6M
$217K 0.13%
10
+5
+100% +$110K
OPK icon
35
Opko Health
OPK
$906M
$214K 0.12%
+20,202
New +$201K
ICPT
36
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$214K 0.12%
1,300
– –
CHRS icon
37
Coherus Oncology
CHRS
$219M
$201K 0.12%
7,500
– –
GNCA
38
DELISTED
Genocea Biosciences, Inc.
GNCA
$200K 0.12%
4,875
– –
GNMX
39
DELISTED
Aevi Genomic Medicine Inc
GNMX
$189K 0.11%
+34,000
New +$194K
ROKA
40
DELISTED
Sorrento Tech, Inc. Common Stock
ROKA
$175K 0.1%
25,231
– –
CERS icon
41
Cerus
CERS
$639M
$165K 0.1%
26,500
– –
PRTK
42
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$145K 0.08%
11,150
– –
TTHI
43
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
$36K 0.02%
23,866
-121,880
-84% -$193K
MCRB icon
44
Seres Therapeutics
MCRB
$49M
– –
-250
Closed -$145K
RLYP
45
DELISTED
RELYPSA INC COM
RLYP
– –
-18,000
Closed -$333K
HNSN
46
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
– –
-528,142
Closed -$2.1M
RPTP
47
DELISTED
RAPTOR PHARMACEUTICAL CORP COM STK (DE)
RPTP
– –
-40,000
Closed -$215K
MDVN
48
DELISTED
MEDIVATION, INC.
MDVN
– –
-18,760
Closed -$1.13M
1
2

Similar funds

RWA
Resolute Wealth Advisor Findlay, Ohio $176M AUM
BAM
Boyar Asset Management New York $176M AUM 20.04% 1-Year Est. Return
TIM
Tevis Investment Management Plano, Texas $176M AUM 18.14% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
FPW
Flywheel Private Wealth Los Altos, California $176M AUM 26.12% 1-Year Est. Return
LWM
Lifetime Wealth Management Rockwall, Texas $176M AUM
PFA
Providence Financial Advisors Overland Park, Kansas $175M AUM
DAM
Draper Asset Management Smithtown, New York $176M AUM 37.45% 1-Year Est. Return

Birchview Capital's Q3 2016 Portfolio in Review

As of Q3 2016, Birchview Capital held 48 positions worth $171M, up 24% from $138M the previous quarter. Its ten largest holdings account for 92% of the portfolio.

Birchview Capital's Q3 2016 filing shows 3 new, 6 increased, 2 reduced and 5 closed positions. Its largest new stake was Opko Health: 20,202 shares worth $214K. The largest sale was HANSEN MEDICAL, INC. COM NEW, an estimated $2.1M.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 92% a quarter earlier, followed by Energy and Consumer Staples.

  • Birchview Capital's largest Q3 2016 buy was Opko Health: 20,202 shares worth $214K.
  • Birchview Capital added most to ContraFect Corporation in Q3 2016, an estimated $613K increase.
  • Birchview Capital's biggest Q3 2016 reduction was Celgene Corp, cutting an estimated $216K.
  • Birchview Capital fully exited HANSEN MEDICAL, INC. COM NEW in Q3 2016, selling an estimated $2.1M.
  • Birchview Capital's ten largest holdings make up 92% of its $171M portfolio in Q3 2016.
  • Birchview Capital opened 3 new positions and closed 5 in Q3 2016.
  • Birchview Capital's portfolio value rose 24% quarter-over-quarter to $171M.

Based on Birchview Capital's 13F filing for Q3 2016, filed 14 Nov 2016.